Table 3:
╲N (%) | All (N=1,191) | Control Group (N=623) | Treatment Group (N=568) | P value* |
---|---|---|---|---|
Gender Female Male |
637 (53.5) 554 (46.5) |
329 (52.8) 294 (47.2) |
308 (54.2) 260 (45.8) |
0.6245 |
Race/Ethnicity | 0.5476 | |||
White | 672 (56.4) | 350 (56.2) | 322 (56.7) | |
Asian | 98 (8.2) | 45 (7.2) | 53 (9.4) | |
Black | 161 (13.5) | 87 (14.0) | 74 (13.0) | |
Hispanic | 232 (19.5) | 124 (19.9) | 108 (19.0) | |
HI/PI/NA | 14 (1.2) | 10 (1.6) | 4 (0.7) | |
Unknown | 14 (1.2) | 7 (1.1) | 7 (1.2) | |
Spanish Speaker | 0.9728 | |||
Yes | 71 (6.0) | 37 (5.9) | 34 (6.0) | |
No | 1,120 (94.0) | 586 (94.1) | 534 (94.0) | |
Age Mean ± Standard Deviation | 67.1 ± 11.8 | 67.1 ± 11.5 | 67.2 ± 12.0 | 0.8355 |
Quality of Life (EQ5D) Mean ± Standard Deviation |
0.65 ± 0.1 | 0.65 ± 0.1 | 0.66 ± 0.1 | 0.4538 |
comparing control and treatment